These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 20030714

  • 1. Factors controlling the effect of praziquantel on liver fibrosis in Schistosoma mansoni-infected patients.
    Rahoud SA, Mergani A, Khamis AH, Saeed OK, Mohamed-Ali Q, Dessein AJ, Elwali NE.
    FEMS Immunol Med Microbiol; 2010 Feb; 58(1):106-12. PubMed ID: 20030714
    [Abstract] [Full Text] [Related]

  • 2. Reversibility of schistosomal periportal thickening/fibrosis after praziquantel therapy: a twenty-six month follow-up study in Ethiopia.
    Berhe N, Myrvang B, Gundersen SG.
    Am J Trop Med Hyg; 2008 Feb; 78(2):228-34. PubMed ID: 18256420
    [Abstract] [Full Text] [Related]

  • 3. Clinical and ultrasound findings before and after praziquantel treatment among Venezuelan schistosomiasis patients.
    Ruiz-Guevara R, de Noya BA, Valero SK, Lecuna P, Garassini M, Noya O.
    Rev Soc Bras Med Trop; 2007 Feb; 40(5):505-11. PubMed ID: 17992403
    [Abstract] [Full Text] [Related]

  • 4. Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice.
    Said E, Said SA, Elkashef WF, Gameil NM, Ammar EM.
    Inflammopharmacology; 2012 Apr; 20(2):77-87. PubMed ID: 22278738
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of the therapeutic activity of praziquantel with the reversal of Symmers' fibrosis induced by Schistosoma mansoni.
    Homeida MA, el Tom I, Nash T, Bennett JL.
    Am J Trop Med Hyg; 1991 Sep; 45(3):360-5. PubMed ID: 1928571
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerance of praziquantel in patients with Schistosoma mansoni infection and Symmers' fibrosis: a field study in the Sudan.
    Homeida MM, el Tom IA, Sulaiman SM, Daffalla AA, Bennett JL.
    Am J Trop Med Hyg; 1988 May; 38(3):496-8. PubMed ID: 3152777
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection.
    Sobhy MMK, Mahmoud SS, El-Sayed SH, Rizk EMA, Raafat A, Negm MSI.
    Exp Parasitol; 2018 Feb; 185():115-123. PubMed ID: 29331278
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.